Literature DB >> 25278040

Engineering of nano-crystalline drug suspensions: employing a physico-chemistry based stabilizer selection methodology or approach.

Mostafa Nakach1, Jean-René Authelin2, Tharwat Tadros3, Laurence Galet4, Alain Chamayou5.   

Abstract

This paper describes a systematic approach to select optimum stabilizer for the preparation of nano-crystalline suspensions of an active pharmaceutical ingredient (API). The stabilizer can be either a dispersant or a combination of dispersant and wetting agent. The proposed screening method is a quick and efficient way to investigate a large number of stabilizers based on the principles of physical-chemistry and employs a stepwise approach. The methodology has been divided in two main parts; the first part being focused on the qualitative screening with the objective of selecting the best candidate(s) for further investigation, the second part has been focused on quantitative screening with the objective to optimize the ratio and amount of wetting and dispersing agents, based on wettability, surface charges measurement, adsorption evaluation, process-ability evaluation and storage stability. The results showed clearly that SDS/PVP 40/60% (w/w) (sodium dodecyl sulfate/poly(vinyl pyrrolidone)) at a total concentration of 1.2% was the optimum stabilizer composition, at which the resulting nanosuspensions were stable for more than 50 days at room temperature.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Beads milling; Dispersant agent; Nano-crystalline suspension; Stabilizer; Top down process; Wetting agent

Mesh:

Substances:

Year:  2014        PMID: 25278040     DOI: 10.1016/j.ijpharm.2014.09.048

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

Review 1.  Mechanistic Modeling of Wet Stirred Media Milling for Production of Drug Nanosuspensions.

Authors:  E Bilgili; G Guner
Journal:  AAPS PharmSciTech       Date:  2020-11-22       Impact factor: 3.246

2.  A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization.

Authors:  Navya Sree Kola Srinivas; Ruchi Verma; Girish Pai Kulyadi; Lalit Kumar
Journal:  Int J Nanomedicine       Date:  2016-12-16

3.  Association between the physical stability of flurbiprofen suspension and the interaction of HPMC/SDS.

Authors:  Hongyu Wang; Yiwei Sun; Baixue Yang; Sanming Li
Journal:  Asian J Pharm Sci       Date:  2017-08-10       Impact factor: 6.598

4.  Development of a Nanostructured Lipid Carrier (NLC) by a Low-Energy Method, Comparison of Release Kinetics and Molecular Dynamics Simulation.

Authors:  Andrea C Ortiz; Osvaldo Yañez; Edison Salas-Huenuleo; Javier O Morales
Journal:  Pharmaceutics       Date:  2021-04-10       Impact factor: 6.321

5.  Nose to brain delivery of Efavirenz nanosuspension for effective neuro AIDS therapy: in-vitro, in-vivo and pharmacokinetic assessment.

Authors:  Smita Kakad; Sanjay Kshirsagar
Journal:  Heliyon       Date:  2021-11-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.